ANTI-IL1RAP ANTIBODY COMPOSITIONS
The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and diagnosis of diseases associated with IL1RAP, such as inflammatory, autoimmune, autoinflammatory and neoplastic disorders.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
23.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and diagnosis of diseases associated with IL1RAP, such as inflammatory, autoimmune, autoinflammatory and neoplastic disorders. |
---|---|
AbstractList | The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and diagnosis of diseases associated with IL1RAP, such as inflammatory, autoimmune, autoinflammatory and neoplastic disorders. |
Author | FORSBERG, Göran LIBERG, David SJÖSTRÖM, Kjell VON WACHENFELDT, Karin |
Author_xml | – fullname: FORSBERG, Göran – fullname: LIBERG, David – fullname: VON WACHENFELDT, Karin – fullname: SJÖSTRÖM, Kjell |
BookMark | eNrjYmDJy89L5WRQdPQL8dT19DEMcgxQALGd_F0iFZz9fQP8gz1DPP39gnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgLGFsbmRhbGjoTERSgC6ACO1 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSITIONS D'ANTICORPS ANTI-IL1RAP ANTI-IL1RAP-ANTIKÖRPERZUSAMMENSETZUNGEN |
ExternalDocumentID | EP3837283A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP3837283A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:01:03 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP3837283A13 |
Notes | Application Number: EP20190755895 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210623&DB=EPODOC&CC=EP&NR=3837283A1 |
ParticipantIDs | epo_espacenet_EP3837283A1 |
PublicationCentury | 2000 |
PublicationDate | 20210623 |
PublicationDateYYYYMMDD | 2021-06-23 |
PublicationDate_xml | – month: 06 year: 2021 text: 20210623 day: 23 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | Cantargia AB |
RelatedCompanies_xml | – name: Cantargia AB |
Score | 3.3360224 |
Snippet | The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | ANTI-IL1RAP ANTIBODY COMPOSITIONS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210623&DB=EPODOC&locale=&CC=EP&NR=3837283A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-KcSgXpW9H0a9lDkTZtWcU2ZVaZT2PtMtjLHK7Df99L6KYv-nYkkE9-ufsluTuAuwez6s8onaPlZs0NeyqIQQcObohVUmITWlKVtC_N3OGr_TR2xi1YbH1hVJzQLxUcERFVId5rdV6vfi6xQvW3cn1fLrDo4zEuvFBv2DHyF1Tnehh4Uc5DznTGUNKzkSeJGGpSH4nSHlrRfQmG6C2QTimr3xolPob9HBtb1ifQEssOHLJt4rUOHKTNezeKDfTWp3DrZ0ViJM9k5OealAMevmuMpzl_SZQv8BlocVSwoYF9TXbzmkT5blTWObSR7osL0NzKtBBVM-I6wqbmoDTRYqjQEkJm5E5t0oXun81c_lPXgyO5QPKbk2ldQbv-3IhrVKh1eaOW4htePXSr |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2J9RpDcgm5e3R6CJLsJieZFjVJPoUlT6KUWG_HvO1nS6kVvwy7sY5ZvZ77dnVmA23u1HM4onaPnps0VfVoRhY4MXBCtoEQntKDi074oNv0X_XFiTDqw2MTCiDyhXyI5IiKqRLzXYr9e_RxicfG2cn1XLLDo_cHLLC637Bj5C5pzmTuWmyY8YTJjKMnx2GqIGFpSG4nSDnrYwwYM7qvTBKWsflsU7wB2U2xsWR9Cp1r2occ2H6_1YS9q77tRbKG3PoIbO84CJQjJ2E6lRnYS_iaxJEqT50DEAh-D5LkZ8xXsK9_OK3fT7ai0E-gi3a9OQTJLVUNUzYhpVDpVR4WKHkOJnhAyI3OqkwEM_mzm7J-6a-j5WRTmYRA_ncN-oyxFJIi8gG798VldonGtiyuhlm8B3nei |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-IL1RAP+ANTIBODY+COMPOSITIONS&rft.inventor=FORSBERG%2C+G%C3%B6ran&rft.inventor=LIBERG%2C+David&rft.inventor=VON+WACHENFELDT%2C+Karin&rft.inventor=SJ%C3%96STR%C3%96M%2C+Kjell&rft.date=2021-06-23&rft.externalDBID=A1&rft.externalDocID=EP3837283A1 |